These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14151938)

  • 1. THE TREATMENT OF MULTIPLE MYELOMA WITH 1-AMINOCYCLOPENTANECARBOXYLIC ACID.
    HELSPER JT; SHARP GS; BENEFIEL WW
    Acta Unio Int Contra Cancrum; 1964; 20():386-8. PubMed ID: 14151938
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of 1-aminocyclopentanecarboxylic acid (NSC-1026) in plasmocytic myeloma.
    MASS RE
    Cancer Chemother Rep; 1963 Apr; 28():17-9. PubMed ID: 13933377
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
    BERGSAGEL DE; ROSS SW; BAKER DT
    Cancer Chemother Rep; 1962 Aug; 21():101-6. PubMed ID: 13867792
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of multiple myeloma with I-aminocyclopentanecarboxylic acid (NSC-1026).
    KRANT MJ; ISZARD DM; ABADI A; CAREY RW
    Cancer Chemother Rep; 1962 Sep; 22():59-64. PubMed ID: 14459328
    [No Abstract]   [Full Text] [Related]  

  • 5. PYROGLOBULINEMIA, AN UNUSUAL PRESENTING SIGN IN MULTIPLE MYELOMA.
    LIPMAN IJ
    JAMA; 1964 Jun; 188():1002-4. PubMed ID: 14132565
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.
    BERGSAGEL DE
    Cancer Chemother Rep; 1962 Feb; 16():261-66. PubMed ID: 13867796
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of 1-aminocyclopentane carboxylic acid (NSC-1026) on mouse plasmacytoma.
    HAYES DM; SPURR CL
    Cancer Chemother Rep; 1961 Oct; 14():91-2. PubMed ID: 13905642
    [No Abstract]   [Full Text] [Related]  

  • 8. THREE CASES OF MULTIPLE MYELOMA.
    DAVIES GM
    Guys Hosp Rep; 1965; 114():108-13. PubMed ID: 14319319
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical studies of an unnatural and antitumor amino acid: 1-aminocyclopentanecarboxylic acid. I. Toxicity and tissue distribution.
    BERLINGUET L; BEGIN N; BABINEAU LM; MARTEL F; VALLEE R; LAFERTE RO
    Can J Biochem Physiol; 1962 Apr; 40():425-32. PubMed ID: 13867937
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE PICTURE OF PROTEINS AND GLYCOPROTEINS IN MULTIPLE MYELOMA].
    BOGDANIKOWA B; MURAWSKI K
    Pol Arch Med Wewn; 1964; 34():119-27. PubMed ID: 14151482
    [No Abstract]   [Full Text] [Related]  

  • 11. A SIMPLE CHEMICAL TEST FOR DISTINGUISHING MYELOMA GLOBULINS FROM MACROGLOBULINS.
    SAIFER A
    J Lab Clin Med; 1964 Jun; 63():1054-60. PubMed ID: 14179122
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical studies of an unnatural and antitumor amino acid: 1-aminocyclopentanecarboxylic acid. II. Effects on cellular respiration and amino acid metabolism.
    BERLINGUET L; BEGIN N; BABINEAU LM; LAFERTE RO
    Can J Biochem Physiol; 1962 Apr; 40():433-6. PubMed ID: 13867939
    [No Abstract]   [Full Text] [Related]  

  • 13. PROTEIN METABOLISM IN PATIENTS WITH MULTIPLE MYELOMA.
    KORMAN S; LIPPINCOTT SW
    Acta Unio Int Contra Cancrum; 1964; 20():1089-95. PubMed ID: 14274705
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON A CASE OF MICROMOLECULAR MYELOMA WITH DEMONSTRATION OF IMMUNOCHEMICAL IDENTITY BETWEEN THE SERUM MICROMOLECULE AND THE URINARY BENCE-JONES PROTEIN].
    BERROD J; LARRAT J; SANDOR G; SUREAU B
    Ann Biol Clin (Paris); 1964; 22():533-41. PubMed ID: 14184012
    [No Abstract]   [Full Text] [Related]  

  • 15. STUDIES OF GAMMA- AND BETA-2A-GLOBULINS. COMPARISON OF IMMUNOCHEMICAL PROPERTIES OF S AND F (PAPAIN) FRAGMENTS OF MYELOMA PROTEINS FROM INBRED MICE.
    FAHEY JL
    J Immunol; 1963 Apr; 90():576-83. PubMed ID: 14082019
    [No Abstract]   [Full Text] [Related]  

  • 16. The heterogeneity of gamma 2-myeloma proteins.
    FRANGLEN G
    Lancet; 1963 Apr; 1(7284):753-4. PubMed ID: 13959222
    [No Abstract]   [Full Text] [Related]  

  • 17. THE METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS.
    ALPER CA; FREEMAN T; WALDENSTROEM J
    J Clin Invest; 1963 Dec; 42(12):1858-68. PubMed ID: 14086772
    [No Abstract]   [Full Text] [Related]  

  • 18. ATYPICAL GAMMA-1-A-GLOBULIN WITH THE ELECTROPHORETIC PROPERTIES OF AN ALPHA-2-GLOBULIN OCCURRING IN MULTIPLE MYELOMA.
    CUMMINGS NA; FRANKLIN EC
    J Lab Clin Med; 1965 Jan; 65():8-17. PubMed ID: 14260870
    [No Abstract]   [Full Text] [Related]  

  • 19. QUANTITATIVE DETERMINATION OF 6.6 S GAMMA-GLOBULINS, BETA-2A-GLOBULINS AND GAMMA-1-MACROGLOBULINS IN HUMAN SERUM.
    FAHEY FL; LAWRENCE ME
    J Immunol; 1963 Nov; 91():597-603. PubMed ID: 14089762
    [No Abstract]   [Full Text] [Related]  

  • 20. [PROTEINS, GLYCOPROTEINS AND LIPOPROTEINS OF THE BLOOD SERUM IN MULTIPLE MYELOMA AND WALDENSTROM'S MACROGLOBULINEMIA].
    ANDREEVA NE; IOFFE RA
    Probl Gematol Pereliv Krovi; 1964 Jun; 9():18-23. PubMed ID: 14216850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.